STOCK TITAN

Cycclone (CDBT) Stock Price, News & Analysis

CDBT OTC

Company Description

Cycclone (OTC: CDBT) is classified in the pharmacies and drug stores industry within the Retail Trade sector.

CDBT has gained 316.7% over the past year. Shares last traded at $0.0600.

This page collects what Stock Titan holds for CDBT, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
0.00%
0.00
Last updated:
+316.7%
Performance 1 year

Cycclone (CDBT) stock last closed at $0.0600. Over the past 12 months, the stock has gained 316.7%.

See what a $1,000 investment in CDBT would be worth today

Latest News

Cycclone has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 1 with negative movement. Key topics include dividends, acquisition. View all CDBT news →

SEC Filings

No SEC filings available for CDBT.

Financial Highlights

Revenue (latest FY)
Net Income (latest FY)
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

CDBT Company Profile & Sector Positioning

Cycclone (CDBT) operates in the Pharmacies and Drug Stores industry within the broader Retail Trade sector and is listed on the OTC.

Frequently Asked Questions

What is the current stock price of Cycclone (CDBT)?

The current stock price of Cycclone (CDBT) is $0.06 as of May 27, 2025.